Related Experiment Video
Updated: Jul 18, 2026
07:55
A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
An in vitro pyrogen safety test for immune-stimulating components on surfaces
Marina Hasiwa1, Karin Kullmann, Sonja von Aulock
1EU Joint Research Centre, European Centre of Validation of Alternative Methods (ECVAM), TP 580, Via Fermi 1, 21020 Ispra, Italy; Biochemical Pharmacology, University of Konstanz, Germany.
Biomaterials
|December 13, 2006
Summary
This study adapted an in vitro pyrogen test using human whole blood to assess biomaterial safety. The test detects inflammatory responses to pyrogens on medical device surfaces, ensuring patient safety.
Area of Science:
- Biomaterials Science
- Immunology
- Medical Device Safety
Background:
- Medical devices increasingly utilize novel materials and surgical techniques.
- Biomaterial contact with human tissues or blood can cause inflammation and adverse health effects due to poor biocompatibility or pyrogenic contamination.
- Current safety testing methods may not fully capture human-relevant inflammatory responses.
Purpose of the Study:
- To adapt and validate the in vitro pyrogen test (IPT) for assessing the safety of biomaterials.
- To evaluate the direct contact of human whole blood with biomaterial surfaces for pyrogen detection.
- To measure the release of Interleukin-1 beta (IL-1β) as a marker of pro-inflammatory response.
Main Methods:
- Human whole blood was directly exposed to the surface of test biomaterials.
- The release of the pro-inflammatory cytokine IL-1β was quantified.
- The assay was tested for its ability to detect various pyrogens including lipopolysaccharide (LPS), lipoteichoic acid (LTA), peptidoglycan, and zymosan.
- Cryo-preserved blood was utilized to assess its impact on detection limits for solid materials.
Main Results:
- The adapted IPT effectively detected pyrogens from Gram-negative and Gram-positive bacteria, as well as fungi, upon direct contact with biomaterials.
- The test demonstrated high sensitivity, with detection limits as low as 10 pg/ml for LPS, 10 ng/ml for zymosan, and 1 μg/ml for LTA and peptidoglycan.
- Using cryo-preserved blood further enhanced the test's sensitivity for detecting pyrogens on solid materials.
Conclusions:
- The adapted in vitro pyrogen test provides a human-relevant assay for evaluating biomaterial safety.
- This method allows for the direct detection of diverse pyrogens on medical device surfaces, addressing biocompatibility and contamination concerns.
- The use of cryo-preserved blood offers an improved detection limit, enhancing the reliability of biomaterial safety assessments.
